Last reviewed · How we verify

NCT06626243: IMMUNORATS

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

Recruiting now Last updated 29 November 2024
What this trial tests

trial in Non-Small Cell Lung Cancer in 140 participants. Currently enrolling.

Timeline
30 September 2024
Primary endpoint
15 February 2025
15 October 2025

Quick facts

Lead sponsorScientific Institute San Raffaele
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment140
Start date30 September 2024
Primary completion15 February 2025
Estimated completion15 October 2025
Sites6 locations across Italy, United States

Conditions studied

Sponsor

Scientific Institute San Raffaele

Who can join

18 and older, any sex, with Non-Small Cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy. There are no risks for the patients, as this is a retrospective data collection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Non-Small Cell Lung Cancer

Currently open trials in the same condition.

Other Scientific Institute San Raffaele trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06626243.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing